Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
150
2025
3049
10.010
Why?
Thalidomide
33
2016
377
2.910
Why?
Boronic Acids
17
2013
183
2.760
Why?
Pyrazines
17
2013
190
2.750
Why?
Bone Marrow
17
2022
364
1.850
Why?
Hematopoietic Stem Cell Transplantation
21
2024
606
1.800
Why?
Venous Thrombosis
8
2009
90
1.660
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1031
1.630
Why?
Paraproteinemias
7
2022
74
1.560
Why?
Angiogenesis Inhibitors
12
2009
183
1.500
Why?
Humans
164
2025
52336
1.350
Why?
Protease Inhibitors
7
2011
61
1.310
Why?
Chromosomes, Human, Pair 1
7
2023
96
1.270
Why?
Proteasome Inhibitors
6
2016
105
1.230
Why?
Prognosis
42
2025
2094
1.230
Why?
Middle Aged
69
2025
13014
1.170
Why?
Aged
66
2025
10109
1.170
Why?
Neoplasm, Residual
7
2025
173
1.150
Why?
Antibodies, Bispecific
6
2025
94
1.150
Why?
Antineoplastic Agents
20
2024
1222
1.130
Why?
Alkaline Phosphatase
7
2020
94
1.120
Why?
Transplantation, Autologous
29
2024
488
1.020
Why?
Thrombosis
6
2013
253
1.020
Why?
Bone Remodeling
3
2016
154
1.000
Why?
Bone Diseases
2
2021
95
1.000
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
125
0.950
Why?
Male
76
2025
26696
0.930
Why?
Female
75
2025
28105
0.910
Why?
Osteogenesis
4
2018
366
0.910
Why?
Gene Expression Profiling
22
2025
1110
0.880
Why?
Immunologic Factors
5
2016
117
0.870
Why?
Anticoagulants
6
2009
267
0.800
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
59
0.800
Why?
Melphalan
12
2016
181
0.790
Why?
Neoplasms, Plasma Cell
4
2024
37
0.790
Why?
Activated Protein C Resistance
4
2011
10
0.760
Why?
Adult
44
2025
14139
0.730
Why?
Parathyroid Hormone
4
2018
149
0.730
Why?
Venous Thromboembolism
3
2011
75
0.710
Why?
Antibodies, Monoclonal
4
2022
481
0.710
Why?
Durapatite
1
2020
23
0.680
Why?
Plasma Cells
10
2025
239
0.680
Why?
B-Cell Maturation Antigen
7
2025
98
0.670
Why?
Disease-Free Survival
21
2019
460
0.650
Why?
Gene Amplification
1
2019
58
0.640
Why?
Thromboembolism
3
2009
50
0.640
Why?
Aged, 80 and over
22
2025
3391
0.640
Why?
Survival Rate
21
2020
940
0.640
Why?
Neoplasm Proteins
7
2020
334
0.640
Why?
Dexamethasone
14
2024
440
0.630
Why?
Myeloablative Agonists
4
2012
32
0.630
Why?
Retrospective Studies
25
2025
6578
0.610
Why?
Disease Progression
17
2025
870
0.600
Why?
Gene Expression Regulation, Neoplastic
12
2021
858
0.590
Why?
Factor V
4
2011
11
0.590
Why?
Oligopeptides
3
2018
93
0.590
Why?
Bone and Bones
4
2021
494
0.590
Why?
Spinal Fractures
1
2018
38
0.580
Why?
Thymus Gland
1
2018
42
0.570
Why?
Parathyroidectomy
1
2018
46
0.570
Why?
Thyroidectomy
1
2018
61
0.560
Why?
Translocation, Genetic
8
2021
265
0.560
Why?
Clinical Trials as Topic
9
2022
468
0.550
Why?
Chromosome Aberrations
11
2023
297
0.540
Why?
Treatment Outcome
31
2022
5407
0.540
Why?
Survival Analysis
14
2024
671
0.540
Why?
Calcification, Physiologic
1
2017
42
0.530
Why?
Follow-Up Studies
22
2024
2268
0.530
Why?
Pelvis
1
2017
69
0.530
Why?
Risk Factors
23
2024
3872
0.520
Why?
Stem Cell Transplantation
11
2023
185
0.520
Why?
Osteoblasts
6
2020
475
0.510
Why?
Thrombophilia
4
2009
19
0.510
Why?
Tumor Microenvironment
5
2024
255
0.480
Why?
Chromosome Deletion
6
2023
142
0.470
Why?
Drug Resistance, Neoplasm
7
2015
327
0.470
Why?
Animals
19
2024
13523
0.450
Why?
Neoplasms
3
2009
1305
0.450
Why?
Transplantation Conditioning
7
2019
93
0.450
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.430
Why?
Neoplasm Recurrence, Local
7
2024
643
0.430
Why?
Polycythemia Vera
1
2013
6
0.420
Why?
Positron-Emission Tomography
4
2025
303
0.410
Why?
Hemostasis
3
2008
60
0.410
Why?
Neovascularization, Pathologic
4
2009
158
0.400
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.400
Why?
Combined Modality Therapy
17
2024
636
0.390
Why?
Mutation
6
2022
1351
0.390
Why?
Neutropenia
2
2023
115
0.380
Why?
Hematopoietic Stem Cells
2
2012
188
0.360
Why?
Bone Neoplasms
2
2010
184
0.350
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Amyloidosis
3
2009
85
0.340
Why?
Doxorubicin
7
2009
239
0.340
Why?
Immunotherapy, Adoptive
4
2024
167
0.320
Why?
Mice
11
2024
5965
0.320
Why?
Anti-Anxiety Agents
1
2009
35
0.320
Why?
In Situ Hybridization, Fluorescence
7
2023
263
0.310
Why?
Kaplan-Meier Estimate
10
2019
484
0.310
Why?
Hemorrhagic Disorders
1
2009
6
0.310
Why?
Cryoglobulinemia
1
2008
13
0.300
Why?
Pain
2
2009
360
0.300
Why?
Biopsy, Needle
1
2009
182
0.300
Why?
Analgesics
1
2009
107
0.290
Why?
Pulmonary Embolism
1
2009
84
0.290
Why?
Recurrence
11
2024
672
0.290
Why?
Collagen
2
2020
212
0.290
Why?
Risk Assessment
7
2023
1323
0.280
Why?
Hematologic Neoplasms
2
2022
106
0.270
Why?
Cell Line, Tumor
4
2023
1436
0.270
Why?
Farnesyltranstransferase
1
2006
4
0.270
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
38
0.270
Why?
Osteolysis
2
2022
75
0.260
Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.260
Why?
Pyrroles
2
2004
71
0.260
Why?
Risk
4
2014
313
0.260
Why?
Neoplasms, Second Primary
2
2024
77
0.260
Why?
Cell Differentiation
4
2022
674
0.260
Why?
Cell Proliferation
8
2023
1029
0.260
Why?
Time Factors
11
2021
2957
0.250
Why?
Sirolimus
1
2006
67
0.250
Why?
Logistic Models
5
2018
920
0.250
Why?
Signal Transduction
6
2021
1716
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Fluorodeoxyglucose F18
4
2021
188
0.230
Why?
Plasmacytoma
2
2020
43
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.230
Why?
Enoxaparin
1
2004
30
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Remission Induction
10
2021
218
0.220
Why?
Indoles
2
2004
278
0.220
Why?
Vascular Endothelial Growth Factor A
2
2004
186
0.220
Why?
Prospective Studies
9
2019
2428
0.200
Why?
Blood Coagulation
1
2003
60
0.200
Why?
Bone Resorption
2
2022
302
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
Why?
Hematopoietic Stem Cell Mobilization
3
2008
60
0.190
Why?
Immunoglobulin Light Chains
2
2017
90
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Randomized Controlled Trials as Topic
3
2012
594
0.190
Why?
Drug Approval
1
2022
46
0.190
Why?
Cell Cycle
2
2021
240
0.190
Why?
Hemorrhage
3
2009
209
0.190
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Chromosomal Instability
2
2019
16
0.190
Why?
Epigenomics
1
2021
75
0.180
Why?
Chromosomes, Human, Pair 13
5
2008
38
0.180
Why?
Patient Participation
1
2022
69
0.180
Why?
SOXC Transcription Factors
1
2021
13
0.180
Why?
T-Lymphocytes
4
2024
340
0.180
Why?
Arkansas
5
2021
2028
0.180
Why?
Calcium Phosphates
1
2020
5
0.170
Why?
Odontoblasts
1
2020
4
0.170
Why?
HL-60 Cells
1
2020
19
0.170
Why?
U937 Cells
1
2020
15
0.170
Why?
Etoposide
5
2009
72
0.170
Why?
K562 Cells
1
2020
41
0.170
Why?
Genes, Tumor Suppressor
2
2021
74
0.170
Why?
NIH 3T3 Cells
1
2020
52
0.170
Why?
Kidney Diseases
2
2020
220
0.170
Why?
MCF-7 Cells
1
2020
62
0.170
Why?
Mammals
1
2020
62
0.170
Why?
Practice Guidelines as Topic
1
2023
487
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Protein C
2
2011
20
0.170
Why?
Myelodysplastic Syndromes
3
2007
86
0.160
Why?
beta 2-Microglobulin
5
2008
39
0.160
Why?
HEK293 Cells
1
2020
232
0.160
Why?
Busulfan
1
2019
17
0.160
Why?
Cisplatin
6
2009
285
0.160
Why?
HeLa Cells
1
2020
263
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Atrial Fibrillation
1
2022
200
0.160
Why?
Imaging, Three-Dimensional
2
2017
150
0.160
Why?
Epigenesis, Genetic
2
2020
407
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Genome-Wide Association Study
1
2020
186
0.150
Why?
Fractures, Compression
1
2018
17
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
Predictive Value of Tests
4
2009
943
0.150
Why?
Spleen
1
2019
173
0.150
Why?
Genomic Instability
2
2016
89
0.150
Why?
Fibrinolysis
2
2009
6
0.150
Why?
Phosphotransferases
1
2018
17
0.150
Why?
Blood Coagulation Factors
2
2009
18
0.140
Why?
Cytokines
3
2007
625
0.140
Why?
Antineoplastic Agents, Alkylating
6
2008
77
0.140
Why?
Bacteremia
1
2019
90
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Cell Line
1
2020
1045
0.140
Why?
Gene Rearrangement
1
2018
75
0.140
Why?
Cluster Analysis
4
2012
232
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Metaphase
4
2016
46
0.140
Why?
Heparin, Low-Molecular-Weight
2
2007
21
0.140
Why?
Ultrasonography, Doppler
2
2007
42
0.130
Why?
Renal Insufficiency
4
2010
113
0.130
Why?
Calcium
1
2018
375
0.130
Why?
Fibrinolytic Agents
2
2007
127
0.130
Why?
Clonal Evolution
1
2016
58
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Tumor Burden
3
2020
136
0.120
Why?
Gene Expression
1
2018
623
0.120
Why?
Disease Models, Animal
4
2016
1484
0.120
Why?
Multivariate Analysis
7
2021
590
0.120
Why?
Bone Marrow Transplantation
4
2022
113
0.120
Why?
Immunotherapy
2
2016
244
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
Genes, Neoplasm
1
2015
31
0.120
Why?
Polymorphism, Single Nucleotide
2
2020
506
0.120
Why?
Gene Dosage
1
2015
78
0.120
Why?
Salvage Therapy
6
2006
136
0.120
Why?
Incidence
2
2009
1059
0.120
Why?
Algorithms
1
2018
668
0.110
Why?
Transcriptome
3
2025
367
0.110
Why?
Osteoclasts
3
2022
428
0.110
Why?
Cystatin M
2
2024
19
0.100
Why?
Altitude
1
2013
16
0.100
Why?
Case-Control Studies
4
2011
1201
0.100
Why?
Janus Kinase 2
1
2013
26
0.100
Why?
Chromosomes, Human, Pair 11
3
2020
55
0.100
Why?
Tomography, X-Ray Computed
2
2017
1162
0.100
Why?
Cross-Sectional Studies
3
2023
1676
0.100
Why?
STAT3 Transcription Factor
2
2010
88
0.100
Why?
Models, Biological
1
2016
743
0.100
Why?
Bone Density Conservation Agents
2
2010
75
0.100
Why?
Protein-Tyrosine Kinases
3
2018
89
0.100
Why?
Creatinine
2
2010
149
0.100
Why?
Cytogenetic Analysis
6
2014
80
0.100
Why?
Mice, Inbred C57BL
1
2018
1903
0.100
Why?
Viremia
1
2012
23
0.100
Why?
Clone Cells
2
2023
77
0.100
Why?
Cytomegalovirus Infections
1
2012
36
0.100
Why?
Models, Genetic
2
2016
172
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Viper Venoms
1
2011
7
0.090
Why?
Drug Evaluation, Preclinical
1
2012
143
0.090
Why?
Epidemiologic Methods
2
2008
46
0.090
Why?
NF-kappa B
2
2018
328
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Arsenicals
1
2010
15
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Oxides
1
2010
21
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.090
Why?
Hypercalcemia
1
2010
34
0.090
Why?
Transplantation, Homologous
4
2003
150
0.090
Why?
Cyclophosphamide
4
2003
171
0.090
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
Why?
Anemia
1
2010
74
0.080
Why?
MAP Kinase Kinase 1
1
2010
23
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Proteinuria
1
2010
39
0.080
Why?
Administration, Oral
2
2009
451
0.080
Why?
Genomics
2
2023
270
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Lorazepam
1
2009
12
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1377
0.080
Why?
Receptors, Retinoic Acid
1
2009
22
0.080
Why?
Hyperhomocysteinemia
1
2009
29
0.080
Why?
Oxycodone
1
2009
26
0.080
Why?
Anesthesia, Local
1
2009
17
0.080
Why?
Prednisone
1
2009
102
0.080
Why?
Histones
2
2021
316
0.080
Why?
Tretinoin
1
2009
54
0.080
Why?
Hemostatic Techniques
1
2009
28
0.080
Why?
Plasma Exchange
1
2009
25
0.080
Why?
Vasculitis
1
2008
30
0.080
Why?
Vincristine
3
2003
88
0.080
Why?
Transcription Factors
2
2023
574
0.070
Why?
Syndecan-1
3
2021
73
0.070
Why?
Biopsy
3
2018
604
0.070
Why?
Drug Therapy, Combination
1
2009
395
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Bone Development
1
2009
66
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Radiopharmaceuticals
2
2021
205
0.070
Why?
Pain Measurement
1
2009
257
0.070
Why?
Carrier Proteins
1
2010
326
0.070
Why?
Platelet Aggregation
1
2008
70
0.070
Why?
Staphylococcal Infections
2
2019
280
0.070
Why?
Thrombocytopenia
1
2009
89
0.070
Why?
Double-Blind Method
1
2009
713
0.070
Why?
Brain Diseases, Metabolic
1
2007
5
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Hyperammonemia
1
2007
24
0.070
Why?
Myeloma Proteins
1
2007
26
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Chi-Square Distribution
1
2007
288
0.070
Why?
Cell Communication
2
2023
72
0.070
Why?
Magnetic Resonance Imaging
4
2007
1543
0.070
Why?
Partial Thromboplastin Time
1
2006
13
0.070
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Heterozygote
1
2006
91
0.060
Why?
Acetaminophen
1
2009
279
0.060
Why?
Antibiotics, Antineoplastic
1
2006
78
0.060
Why?
Gastrointestinal Neoplasms
1
2006
42
0.060
Why?
Models, Statistical
1
2007
230
0.060
Why?
Pilot Projects
1
2008
719
0.060
Why?
Age Factors
3
2005
1127
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Apoptosis
1
2010
1127
0.060
Why?
Gene Deletion
2
2003
276
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Syndrome
2
2019
247
0.060
Why?
ROC Curve
1
2025
251
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
116
0.050
Why?
Glucuronidase
1
2003
47
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
DNA Methylation
2
2020
592
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Antibodies
1
2024
152
0.050
Why?
Immunosuppressive Agents
1
2005
243
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
412
0.050
Why?
Myeloproliferative Disorders
1
2003
31
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Antigens, CD34
1
2003
73
0.050
Why?
Tumor Cells, Cultured
3
2010
456
0.050
Why?
Platelet Count
3
2008
75
0.050
Why?
Rats
1
2009
3202
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
66
0.050
Why?
Leukemia, Myeloid
1
2002
42
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
55
0.050
Why?
Drug Interactions
1
2002
205
0.050
Why?
Chromosome Disorders
1
2002
32
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
United States Food and Drug Administration
1
2022
98
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Enzyme Inhibitors
1
2004
374
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Hypothyroidism
1
2002
57
0.050
Why?
Central Nervous System Neoplasms
1
2002
69
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
91
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.040
Why?
Cohort Studies
2
2020
1532
0.040
Why?
Chromatin
1
2021
141
0.040
Why?
Pyrimidines
1
2022
199
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
236
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Endothelium, Vascular
1
2002
261
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Longitudinal Studies
2
2016
741
0.040
Why?
Transcriptional Elongation Factors
1
2020
17
0.040
Why?
Protein Kinase Inhibitors
1
2022
230
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Postoperative Complications
1
2007
1066
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
RNA, Messenger
3
2010
1142
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Health Status Disparities
1
2022
216
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
179
0.040
Why?
Neoplastic Stem Cells
2
2015
93
0.040
Why?
Computational Biology
1
2020
211
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Proline
1
2018
32
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
DNA-Binding Proteins
1
2021
429
0.040
Why?
Recombinant Proteins
2
2010
491
0.040
Why?
Fluorescent Dyes
1
2018
91
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Proteolysis
1
2018
102
0.040
Why?
Oncogene Proteins, Fusion
1
2018
61
0.040
Why?
Extracellular Matrix
1
2018
112
0.040
Why?
Kidney Function Tests
1
2017
54
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Cell Movement
1
2018
277
0.030
Why?
Glomerular Filtration Rate
1
2017
124
0.030
Why?
Amino Acid Sequence
1
2018
591
0.030
Why?
Genetic Predisposition to Disease
1
2020
528
0.030
Why?
Cell Survival
2
2010
602
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Mice, SCID
2
2009
182
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Chromosome Mapping
2
2006
155
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
150
0.030
Why?
Serum Albumin
2
2008
58
0.030
Why?
Syndecans
2
2006
37
0.030
Why?
Proteoglycans
2
2006
87
0.030
Why?
Cells, Cultured
1
2018
1589
0.030
Why?
Drug Monitoring
1
2015
83
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Myocardium
1
2017
480
0.030
Why?
Proportional Hazards Models
2
2006
443
0.030
Why?
Membrane Glycoproteins
2
2006
244
0.030
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
Neoplasm Staging
2
2007
770
0.020
Why?
Infusions, Intravenous
2
2003
220
0.020
Why?
RNA Interference
1
2013
186
0.020
Why?
Cytomegalovirus
1
2012
30
0.020
Why?
Viral Load
1
2012
80
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Graft vs Host Disease
2
2003
88
0.020
Why?
United States
1
2022
5182
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
177
0.020
Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
Why?
Femur
1
2010
133
0.020
Why?
Long-Term Care
1
2010
51
0.020
Why?
RNA, Small Interfering
1
2010
218
0.020
Why?
Peripheral Nervous System Diseases
1
2010
59
0.020
Why?
Down-Regulation
1
2010
347
0.020
Why?
Bone Diseases, Metabolic
1
2010
78
0.020
Why?
Abnormalities, Multiple
1
2010
167
0.020
Why?
Cell Transformation, Neoplastic
1
2010
184
0.020
Why?
Protein Isoforms
1
2009
126
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Ligands
1
2009
207
0.020
Why?
Polyethylene Glycols
1
2008
89
0.020
Why?
Rabbits
1
2009
374
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
583
0.020
Why?
Hemoglobins
1
2008
110
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
Diagnosis, Differential
1
2010
1044
0.020
Why?
C-Reactive Protein
1
2008
155
0.020
Why?
Mass Screening
1
2010
357
0.020
Why?
Ammonia
1
2007
86
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Brain
2
2007
1323
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Bone Density
1
2009
399
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Evidence-Based Medicine
1
2007
261
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Radiography
1
2007
470
0.020
Why?
Coculture Techniques
1
2006
145
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.020
Why?
Data Interpretation, Statistical
1
2006
164
0.020
Why?
Neoplasms, Experimental
1
2006
113
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Survivors
1
2006
118
0.010
Why?
Mice, Transgenic
1
2006
563
0.010
Why?
Databases, Factual
1
2007
706
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
558
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
Endothelial Growth Factors
1
2003
10
0.010
Why?
History, 21st Century
1
2003
59
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
14
0.010
Why?
Lymphokines
1
2003
20
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
Why?
History, 20th Century
1
2003
96
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Confidence Intervals
1
2003
158
0.010
Why?
Interphase
1
2003
10
0.010
Why?
Probability
1
2003
171
0.010
Why?
Diploidy
1
2003
25
0.010
Why?
Leukocyte Count
1
2003
73
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
Interferons
1
2002
38
0.010
Why?
Sex Factors
1
2005
727
0.010
Why?
Cell Count
1
2003
144
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
106
0.010
Why?
Drug Administration Schedule
1
2003
372
0.010
Why?
Thyroid Function Tests
1
2002
27
0.010
Why?
Thyrotropin
1
2002
49
0.010
Why?
Prevalence
1
2005
1007
0.010
Why?
Fatal Outcome
1
2002
196
0.010
Why?
Neutrophils
1
2003
146
0.010
Why?
Tissue Donors
1
2003
126
0.010
Why?
Cell Division
1
2002
291
0.010
Why?
Reoperation
1
2003
465
0.010
Why?
Acute Disease
1
2002
374
0.010
Why?
Up-Regulation
1
2002
462
0.010
Why?
Anti-Bacterial Agents
1
2003
801
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description